Randomized Controlled Trial of a Positive Affect Intervention to Reduce Stress in People Newly Diagnosed with HIV; Protocol and Design for the IRISS Study by Moskowitz, J T et al.
The University of San Francisco
USF Scholarship: a digital repository @ Gleeson Library |
Geschke Center
School of Education Faculty Research School of Education
2014
Randomized Controlled Trial of a Positive Affect
Intervention to Reduce Stress in People Newly
Diagnosed with HIV; Protocol and Design for the
IRISS Study
J T. Moskowitz
A W. Carrico
M A. Cohn
L G. Duncan
Cori Bussolari
University of San Francisco, bussolari@usfca.edu
See next page for additional authors
Follow this and additional works at: http://repository.usfca.edu/soe_fac
Part of the Education Commons, and the Medicine and Health Sciences Commons
This Article is brought to you for free and open access by the School of Education at USF Scholarship: a digital repository @ Gleeson Library | Geschke
Center. It has been accepted for inclusion in School of Education Faculty Research by an authorized administrator of USF Scholarship: a digital
repository @ Gleeson Library | Geschke Center. For more information, please contact repository@usfca.edu.
Recommended Citation
Moskowitz J.T., Carrico A.W., Cohn M.A., Duncan L.G., Bussolari C., Layous K., Hult J.R., Brousset A., Cotten P., Maurer S., Pietrucha
M.E., Acree M., Wrubel J., Johnson M.O., Hecht F.M., Folkman S. Randomized controlled trial of a positive affect intervention to
reduce stress in people newly diagnosed with HIV; protocol and design for the IRISS study (2014) Open Access Journal of Clinical
Trials, 6, pp. 85-100. DOI: 10.2147/OAJCT.S64645
Authors
J T. Moskowitz, A W. Carrico, M A. Cohn, L G. Duncan, Cori Bussolari, K Layous, J R. Hult, A Brousset, P
Cotten, S Maurer, M E. Pietrucha, M Acree, J Wrubel, M O. Johnson, F M. Hecht, and S Folkman
This article is available at USF Scholarship: a digital repository @ Gleeson Library | Geschke Center: http://repository.usfca.edu/
soe_fac/24
© 2014 Moskowitz et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Open Access Journal of Clinical Trials 2014:6 85–100
Open Access Journal of Clinical Trials Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
85
S T u dy  P r O T O C O l
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/OAJCT.S64645
randomized controlled trial of a positive affect 
intervention to reduce stress in people newly 
diagnosed with HIV; protocol and design for the 
IrISS study
Judith Tedlie Moskowitz1
Adam W Carrico2
Michael A Cohn3  
larissa G duncan4
Cori Bussolari5
Kristin layous6
Jen r Hult7
Alex Brousset8
Paul Cotten3
Stephanie Maurer3
Martha E Pietrucha3
Michael Acree3
Judith Wrubel3
Mallory O Johnson9,10
Frederick M Hecht3
Susan Folkman9,10
1department of Medical Social Sciences, Feinberg 
School of Medicine, Northwestern university, 
Evanston, Il, 2Community Health Systems, 
School of Nursing, university of California San 
Francisco, San Francisco, CA, 3Osher Center for 
Integrative Medicine, university of California San 
Francisco, San Francisco, CA, 4department of 
Family and Community Medicine, Osher Center 
for Integrative Medicine, university of California 
San Francisco, San Francisco, CA, 5department 
of Counseling Psychology, School of Education, 
university of San Francisco, San Francisco, 
CA, 6department of Psychology, university of 
California riverside, riverside, CA, 7Institute for 
Health Policy Studies, university of California San 
Francisco, San Francisco, CA, 8Center for HIV 
Education Studies and Training, City university 
of New york, New york, Ny, 9Osher Center for 
Integrative Medicine, university of California San 
Francisco, San Francisco, CA, 10department of 
Medicine, university of California San Francisco, 
San Francisco, CA, uSA
Correspondence: Judith T Moskowitz 
department of Medical Social 
Sciences, 633 N. St. Clair, Suite 1900, 
Chicago, Il 60611, uSA 
Email judith.moskowitz@northwestern.
edu
Abstract: Increasing evidence suggests that positive affect plays an important role in adaptation 
to chronic illness, independent of levels of negative affects like depression. Positive affect may be 
especially beneficial for people in the midst of severe stress, such as the diagnosis of human immu-
nodeficiency virus (HIV). As medical treatments for HIV have improved, the number of people 
living with HIV has increased, and prevention strategies tailored specifically to people living with 
HIV have become a priority. There is a need for effective, creative, client-centered interventions that 
can be easily disseminated to community treatment settings, but there are currently few established 
interventions for people who are newly diagnosed with HIV. We present the design and methods for a 
randomized trial in which we test the efficacy of one such skills-based intervention that targets positive 
affect as a novel mechanism of change. The proposed research builds on observational findings of 
the important unique functions of positive affect. We aim to determine whether a five-session theory- 
and evidence-based intervention designed to teach skills for increasing the frequency and intensity 
of daily positive affect does so, and whether this intervention has beneficial effects on subsequent 
psychological well-being, health behaviors, and physical health up to 15 months after diagnosis with 
HIV. This is a randomized controlled trial in a sample of adults recruited within 12 weeks of testing 
positive for HIV. The control group is attention-matched, and follow up assessments will be conducted 
immediately post intervention (approximately 5 months post diagnosis) and at 10 and 15 months 
post diagnosis. This study is an important next step in research concerning the adaptive functions of 
positive affect for people coping with HIV or other health-related life stress.
Keywords: positive affect, HIV diagnosis, stress, coping, RCT, intervention, physical health
Introduction
Depression is common in people living with human immunodeficiency virus1 (HIV) and 
is associated with substance abuse,2–4 suboptimal medication adherence,5–7 increased 
HIV transmission risk behavior,3 and hastened HIV disease progression.8–10 Depres-
sion, however, is only part of the emotion picture. Increasing evidence suggests that 
positive affect plays an important role in adaptation to chronic illness, independent of 
levels of negative affects like depression.11,12 Positive affect may be especially beneficial 
for people in the midst of severe stress, such as the diagnosis of HIV.13–16 A growing 
body of research shows that positive affect has unique beneficial associations with 
psychological and physical health in the context of health-related stress.13,17–21
In the era of HIV treatment as prevention (TaSP), initiating anti-retroviral therapy 
(ART) immediately following HIV diagnosis has the potential to optimize health out-
comes and reduce transmission rates by promoting sustained HIV viral suppression.22 
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However, newly diagnosed HIV-positive persons experience 
substantial barriers such as depression and substance use that 
hinder linkage to and engagement in HIV medical care.23 
Interventions for people with HIV targeting depression, 
stress, and associated HIV risk behaviors have shown modest 
effects,24–28 but there remains a clear need for improvement.29 
The prevalence of comorbid depression in HIV remains 
elevated,30 HIV incidence has not dropped appreciably,31 and 
a significant proportion of people living with HIV continue 
to engage in behaviors that put them at risk for other sexually 
transmitted diseases and their partners at risk of infection 
with HIV.32
There is a need for effective, creative, client-centered 
interventions to realize the potential benefits of TasP and 
to facilitate optimal adjustment to HIV. We present the 
clinical trial design and rationale for a skills-based inter-
vention for people newly diagnosed with HIV that targets 
positive affect as a fundamental and novel mechanism of 
change, and promotes resilience in the midst of serious 
life stress. This randomized controlled trial (RCT) tests 
whether a five-session theory- and evidence-based interven-
tion designed to teach skills for increasing the frequency 
and intensity of daily positive affect does so, and whether 
these intervention-related increases in positive affect have 
beneficial effects on subsequent psychological well-being, 
health behaviors, and physical health up to 15 months after 
diagnosis with HIV.
The stress of being  
diagnosed with HIV
People newly diagnosed with HIV are in the acute phase of 
a major stressful life event and face significant challenges 
including the need to interact with a complex health care 
system; constraints on sexual behavior; decision-making 
around disclosure of serostatus to friends, family, and sexual 
partners; stigma; and in many cases a struggle to come to 
terms with a new identity as someone living with HIV.33,34
The period immediately following human immunodefi-
ciency virus positive (HIV+) serostatus notification is charac-
terized by increases in depression and anxiety.35–41 Even years 
after diagnosis, people living with HIV are at elevated risk of 
depression,1 which is associated with a number of negative 
outcomes including increased sexual risk behavior3 and more 
rapid HIV disease progression.8–10 Although interventions 
designed to reduce depression in people living with HIV 
have met with some moderate success,24,28,42 very few have 
targeted those who are newly diagnosed with HIV.
Stress and the relevance  
of positive affect
The intervention we present here focuses on positive affect. 
Both theory and research support this approach. We use the 
term “affect” broadly, to include any positively or negatively 
valenced subjective feeling state. Examples of positive affects 
are: happiness, contentment, joy, satisfaction, gratitude, 
relief, and pleasure. These are differentiated from negative 
affects such as sadness, anger, fear, disgust, shame, and 
distress. We are interested in the impact of the intervention 
on the frequency and intensity of positive affects and their 
impact on subsequent health behaviors and well-being.
Positive affect co-occurs with negative 
affect during stressful periods
Positive affect can occur with relatively high frequency, even 
in the midst of dire stressful circumstances, and can occur at 
the same time that symptoms of depression and distress are 
significantly elevated. In our study of caregiver partners of 
men with Acquired Immune Deficiency Syndrome (AIDS), 
the depression scores of the caregivers in the study were in the 
range that would classify them as at risk for clinical depression, 
both during caregiving and after the death of the partner.43 
However, with the exception of the time immediately surround-
ing the death of the partner, when asked to report how often 
they experienced various positive and negative affects in the 
previous week, the participants reported experiencing overall 
positive affect as least as frequently as they experienced overall 
negative affect.13 Three years after the death of the partner, the 
mean depression score of the bereaved caregivers was still 
significantly higher than the general population mean.44 Again, 
however, positive affect was prevalent.
Adaptational significance of positive  
affect during stressful periods
The fact that positive affect co-occurs with negative affect 
suggests that positive affect is adaptive in the context 
of stress.13–16,45–47 Several empirical studies support this 
hypothesis. For example, in a 12-week study of women with 
arthritis or fibromyalgia, positive affect was associated with 
reduced pain and lowered negative affect, and this relation-
ship was stronger during weeks when participants reported 
higher levels of stress.48 Similarly, in a longitudinal study of 
widows, daily positive affect buffered the effect of stress on 
negative affect. Compared to periods of low stress, positive 
affect in periods of high stress predicted lower levels of 
negative affect.49
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Laboratory and epidemiological studies suggest positive 
affect may also affect physiological outcomes, morbidity, 
and mortality. For example, laboratory studies suggest that 
positive affect may have beneficial physiological effects in 
the context of stress. Fredrickson and Levenson50 induced 
negative affect in subjects by showing them a film that elicited 
fear. Subjects were then shown one of four films designed to 
elicit contentment or amusement (positive affect), sadness 
(negative affect), or no affect (neutral condition). Measures 
of cardiovascular reactivity indicated that those individuals 
who were shown the contentment or amusement film had 
faster recovery to baseline than subjects shown the sad or 
neutral film.
With respect to morbidity and mortality, studies have 
indicated that positive affect is uniquely associated with 
lower risk of morbidity and mortality across both chronically 
ill and healthy samples.12,51 Mroczek et al52 demonstrated 
that although levels of positive and negative affect over the 
course of an 8-day diary study were not predictive of 10-year 
mortality risk, positive affect reactivity (the extent to which 
positive affect dropped in response to a stressful event) was. 
Participants who maintained their normal level of positive 
affect during days in which they experienced a stressor had 
lower mortality than those whose positive affect dropped.
In a sample of men with AIDS, participants with higher 
average scores on the positive affect subscale from the Center 
for Epidemiological Studies Depression scale (CES-D) had 
lower risk (RR) of mortality compared to those with lower 
positive affect: RR = 0.89, 95% CI –0.84–0.95.20 When risk 
estimates were adjusted for the time-dependent covariates 
of CD4, antiretroviral use, and the other subscales of the 
CES-D, positive affect remained significantly predictive of 
lower risk of AIDS mortality (RR =0.90, CI =0.85–0.97). 
These provocative, observational studies suggest that positive 
affect may counteract some of the negative physiological and 
psychological effects associated with stress and, ultimately, 
lead to better health outcomes.
Mechanisms through which  
positive affect might influence  
clinical outcomes
One pathway through which positive affect may buffer 
adverse effects of stress is by increasing coping resources, 
such as social support, that enable the individual to cope 
better with the stress of HIV in a variety of ways.53  Positive 
affect is hypothesized to facilitate social support, and social 
support has been shown to be associated with longer survival 
and slower progression of HIV.54,55 In HIV-negative samples, 
positive affect is associated with greater social connected-
ness, when controlling for negative affect and other potential 
confounders.56 In another study, Keltner and Bonanno57 
found that bereaved individuals who showed genuine laughs 
or smiles (as determined by coding of facial expressions), 
while describing their relationship with their deceased 
spouse, elicited more positive affect and less frustration 
in observers than bereaved individuals who did not show 
the genuine laughs or smiles. Perhaps more importantly, 
untrained observers indicated that they would be more 
likely to offer comfort to those individuals who showed 
the genuine laughs or smiles. These findings suggest that 
individuals may elicit social support from others by their 
displays of positive affect.
Positive affect may influence risk of mortality by bolster-
ing the immune system directly. Various immune parameters 
have been shown to be susceptible to influence by experi-
mentally induced, as well as naturally occurring, affective 
states.58,59 These findings may not fully generalize to individu-
als with HIV, but HIV-specific studies suggest that similar 
processes occur. Ickovics et al60 found that psychological 
resources (an index that combined positive affect, positive 
health expectancies, and finding meaning) were associated 
with lower risk of mortality and slower CD4 decline, suggest-
ing a possible immune mediator of the link between positive 
psychological states and physical health in people with HIV. 
Work by Antoni et al demonstrates that stress management 
interventions designed to reduce distress in HIV+ samples 
improve immune function (eg, increased CD4/CD8 ratio, 
increased natural killer [NK] cytotoxicity).54,61–64 Although 
stress management interventions both increase positive 
affect and decrease negative affect, positive affect has not 
been explicitly assessed as a mediator of the association of 
stress reduction interventions and improvement in immune 
parameters.
Positive affect may also lower risk of morbidity and mortal-
ity via improved health behaviors. A study of daily affect and 
sexual risk behavior in men who have sex with men (MSM) 
demonstrated a unique effect of positive affect: participants 
who reported higher positive affect were less likely to engage 
in risky sexual behavior, controlling for negative affect and 
sexual feelings.65 Positive affect is associated with subse-
quent reductions in stimulant use among MSM,66 and recent 
work demonstrates that positive affect predicts subsequent 
engagement in health care among people newly diagnosed 
with HIV.17 Positive affect may facilitate attention to and 
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processing of health-relevant information, which is a crucial 
step in health-promoting behaviors.67,68 These findings extend 
evidence on the effects of positive affect into the realm of health 
behavior, suggest the possibility that increases in positive affect 
may help HIV+ individuals attend to information regarding 
their health, and perhaps facilitate more effective health care 
utilization. We hypothesize that a positive affect intervention 
will increase positive affect which will, in turn, be associated 
with improved health behaviors (Figure 1).
Theoretical foundation  
of the intervention
The intervention is based on revised stress and coping 
theory13,69 and the broaden-and-build theory of positive 
emotion.53 Folkman13 proposed a revision to stress and coping 
theory that explicitly posits a role for positive affect in the 
coping process. According to the original theory,70 the cop-
ing process begins when an event is appraised as threatening, 
harmful, or challenging. These appraisals are associated 
with affect (negative affect in response to threat or harm, a 
mix of positive and negative in response to challenge), and 
prompt coping. If the event is resolved favorably, a positive 
affective state is the result. If the event is resolved unfavor-
ably or if it is unresolved, a negative affective state results 
and the coping process continues through reappraisal and 
another round of coping. The revised model suggests that 
the negative affect associated with unfavorable resolution 
motivates coping processes that draw on important goals 
and values, including positive reappraisal and goal-directed 
problem-focused coping. These coping processes result in 
positive affect, which serves important coping functions: 
positive affect provides a psychological “time-out” from the 
distress associated with chronic stress, and it helps motivate 
and sustain ongoing efforts to cope with the negative effects 
of the chronic stress. In the context of a new HIV diagnosis, 
positive affect may facilitate more adaptive coping such as 
positive reappraisals where individuals change their thoughts 
about stressful circumstances to see them in a more positive 
light (eg, “this has made me a stronger person.”) It may also 
be that positive affect leads to decreased reliance on avoidant-
oriented coping strategies (eg, stimulant and other drug use, 
and unsafe sexual behavior).
Fredrickson53 proposed the “broaden-and-build” model 
of the function of positive affect that complements revised 
stress and coping theory. In this model the “broadening” 
function of positive affect enables the individual to see 
beyond the immediate stressor and possibly come up with 
creative alternative solutions to problems. The “building” 
function helps to rebuild resources (such as self-esteem and 
social support) depleted by enduring stressful conditions. 
In contrast to the narrowing of attention and specific action 
tendencies associated with negative affect, positive affect 
broadens the individual’s attentional focus71–73 and behav-
ioral repertoire.71,74 Repeated experiences of positive affect 
build social, intellectual and physical resources that buffer 
against the deleterious effects of stress.45,75–77 Although the 
broaden-and-build model is not specific to stress, under 
stressful conditions the functions of positive affect suggested 
by the model become especially important. In the context of 
a new HIV diagnosis, positive affect may support adjustment 
to living with this chronic illness, and enhance receptivity 
to health promotion messages (the broadening function) in 
the critical period when newly diagnosed individuals are 
establishing new self-care behaviors, including engagement 
in health care and safer sexual behaviors.
Design and methods
The study, called IRISS (Intervention for those Recently 
Informed of their Seropositive Status), is a five-session positive 
affect skills intervention compared to an attention-matched 
control condition, in which participants have five sessions of 
interviews concerning coping and affect. Both intervention 
and control sessions are approximately one hour long and are 
administered one-on-one by trained facilitators. Participants in 
both conditions have daily home practice over the 5 weeks of 
the intervention. At the end of the 15-month assessment period, 
participants in the control condition are offered the opportunity 
to learn the skills in a self-paced online format.
Participants
Eligibility
To be enrolled in this RCT, participants must: 1) have been 
informed they were HIV positive within the past 12 weeks; 
Improved health
behaviors
Enhanced
QOL,
reduced
depression
Enhanced
daily positive
affect
Broadened cognition and
enhanced resources
(eg, supportive relationships,
problem-solving, resilience)
Stress and coping
benefits
(challenge vs threat appraisals,
psychological “time out”)
Improved health
markers/outcomes
Figure 1 Theoretical model of pathways through which positive affect is associated 
with health.
Abbreviation: QOl, quality of life.
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2) speak English or Spanish; 3) be 18 years or older; and 
4) have the ability to provide informed consent to be a 
research participant. Exclusion criteria include: 1) Inability 
to provide informed consent, as evidenced by cognitive 
impairment; 2) active psychosis; and 3) unmedicated bipo-
lar disorder. All procedures were approved by the relevant 
Human Subjects Committees, and all participants provided 
written informed consent.
Study procedures
recruitment
Participants were recruited through HIV testing sites and 
clinics, community based organizations, newsletters, and 
fliers. Potential participants were informed that the goal of 
the study was to find out what’s effective in helping people 
cope with a new diagnosis. Study materials and consent 
forms explained that participants would be assigned to one 
of two conditions in which they would either “learn skills 
to better manage your mood” or “talk about what’s going 
on since testing positive.” They were also told they would 
have three blood draws to measure CD4 and viral load, and 
would receive up to $250 for completing nine visits over 
15 months. Interested participants were referred to the study 
for screening. Participants who were eligible were then 
scheduled for their first assessment session.
Consent, assessments, and randomization
Scheduled assessments take place at four points: Time 1 
(baseline) at entry into the study within approximately 
3 months post diagnosis; Time 2, at one week post-
 intervention (approximately 5 months post diagnosis); 
Time 3 (approximately 10 months post diagnosis); 
Time relative to HIV
diagnosis
Study activity
Recruitment
3 months
5 months
10 months
15 months
Time 2 assessment
interview
Time 3 assessment
interview, blood draw
Time 4 assessment
interview, blood draw
Time 1 (baseline) assessment
consent, interview, blood draw
Randomization
Control arm
5 weekly in-person sessions
Intervention arm
5 weekly in-person sessions
1. Life history 1. Positive events, capitalizing, gratitude
2. Health history 2. Mindfulness
3. Positive reappraisal
4. Personal strengths and goals
5. Acts of kindness
3. Personality and diet
4. Social network and support
5. Meaning and purpose
Phone evaluation of control
sessions
Phone evaluation of 
 intervention sessions
Figure 2 Study recruitment and assessment timeline.
Abbreviation: HIV, human immunodeficiency virus.
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and Time 4 (approximately 15 months post diagnosis.) CD4 
and viral load are collected at Time 1,Time 3, and Time 4 
(15 months post diagnosis). See Figure 2.
Assessments are conducted one-on-one by trained inter-
viewers who are blind to whether the participant was in the 
intervention or the control condition. Assessments consist 
of quantitative self-reports on positive and negative affect, 
health behaviors, physical health, coping, social support, and 
personality; measures are shown in Table 1. Qualitative data are 
collected on recent HIV-related stressful events. We use com-
puter assisted personal interviewing and all interviews are audio 
recorded for quality control and later transcription and analysis 
of the narrative portions. Participants are video recorded during 
their stressful event narrative at Times 1, 2, and 4 for coding of 
facial expressions of emotion. All study materials have been 
translated into Spanish by a certified translator.
At the first assessment session, participants complete 
informed consent procedures, have an initial blood draw for 
CD4 and viral load, and complete the baseline interview. 
Once the baseline assessment is completed, the participant 
is randomly assigned to the intervention or control condition 
using block randomization with randomly-varying block 
sizes of two, four, or six.
Content of the intervention
Elsewhere, we have detailed the rationale for inclusion 
of each of the positive affect skills.78 Briefly, the IRISS 
intervention consists of five in-person sessions and one 
phone session in which facilitators teach participants eight 
empirically-supported behavioral and cognitive “skills” for 
increasing positive affect. The eight skills are: 1) noting daily 
positive events;79 –82 2) capitalizing on or savoring positive 
events;83,84 3) gratitude;85–87 4) mindfulness;88–91 5) positive 
reappraisal;13,24,42,92–96 6) focusing on personal strengths;97–99 
7) setting and working toward attainable goals;42,95,100–103 and 
8) small acts of kindness.104–108
The first session begins with an overview of the interven-
tion approach and philosophy. We explicitly acknowledge to 
the participant that testing positive for HIV is very stressful 
for most people and that we are not advocating a simplistic 
“don’t worry – be happy” approach. We explain to participants 
that although this is a structured, positive affect skills-building 
intervention, they should feel free to discuss their HIV status 
or other stressors in the sessions if and when it feels comfort-
able to them. We also do not require participants to discuss 
these issues. We emphasize that our goal is to help participants 
give time and attention to the positive experiences and associ-
ated emotions, even in the context of serious life stress.
Session 1
In the first session, we focus on positive events, capitaliz-
ing, and gratitude. The facilitator explains that even under 
extremely stressful conditions, people have the capacity to 
experience positive events. The purpose of this part of the 
session is to help participants recognize positive events and 
the associated positive affect associated with those events. 
During this part of the session, the facilitator helps partici-
pants understand that when they experience a positive event, 
they may capitalize on it by “turning up the volume” (ie, 
increasing the intensity) of the associated positive affect by 
telling someone about it, writing about it, or simply reflect-
ing on the event and re-experiencing it.83 The home practice 
after Session 1 consists of the participant noting a positive 
event each day and writing about it (capitalizing), and start-
ing a daily gratitude journal in which the participant lists at 
least one thing to be grateful for that day. The gratitude list 
continues through the rest of the 5-week intervention period. 
Participants are encouraged to list small things (eg, a good 
cup of coffee, a smile from a stranger) as well as bigger 
things. Finally, participants are asked to complete a daily brief 
measure of positive and negative affect on their own (control 
group participants also complete this measure).
Session 2
The focus in Session 2 is mindfulness, a state in which one 
focuses on the present moment, accepting and acknowledging 
it without getting caught up in emotional reactions or rumina-
tive thoughts about the situation. During this session, the facili-
tator discusses the concept of developing mindfulness through 
formal practice, and then practices a formal mindfulness activ-
ity with the participant, eg, sitting quietly and paying attention 
to the breath, guided by a 10-minute “breath awareness” audio 
recording. The audio instructions and the discussion follow-
ing the breath awareness activity emphasize nonjudgment of 
thoughts and feelings that arise during the activity. We give 
participants a copy of the audio recording to use for their home 
practice (and loan them an audio listening device if they do not 
have one readily available for their use). This is followed by 
discussion and practice of informal mindfulness (mindfulness 
of daily activities such as a phone conversation, walking or 
driving, or doing a household chore). Home practice for the 
week following Session 2 consists of daily informal mindful-
ness activities, the 10-minute formal breath awareness activity, 
and continuing the gratitude journal and daily emotion reports 
that were started in the first week. Participants are instructed 
to continue the daily breath awareness activity throughout the 
remaining weeks of the intervention.
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Table 1 Outcome, moderator, and intervention-based measures
Measure Description
Outcomes (Times 1 through 4 unless otherwise noted)
Affect
Modified Differential Emotions  
Scale (mdES)45
This version of the dES includes a wider range of positive emotions than the original scale. The full scale 
assesses interest, enjoyment, surprise, sadness, anger, disgust, contempt, fear, guilt, shame, shyness, 
amusement, awe, contentment, gratitude, hope, love, pride, sympathy, and sexual feelings. Participants 
rate how frequently they felt that particular affect in the past week on a five-point scale: 0= never, 1= 
hardly, 2= some of the time, 3= often, and 4= most of the time.
Positive and Negative Affect  
Schedule (PANAS)117
The PANAS was designed to assess two relatively independent constructs: high activation positive 
affect (eg, interested, excited, enthusiastic) and high activation negative affect (upset, irritable, ashamed). 
respondents are asked to indicate how strongly they felt each affect during the past week on a scale from 
0= not at all to 4= extremely.
daily affect diary Over the 5 weeks of the intervention, both intervention and control group participants report their affect 
at the end of each day in a diary format. For this purpose we reworded the mdES described above to 
indicate a time frame of “today” instead of “past week.”
Mental health
PrIME-Md118 The Prime Md assesses clinical depression with ten questions regarding depressive symptoms (eg, trouble 
falling asleep or staying asleep, poor appetite or overeating, little interest or pleasure in doing things). 
A respondent is considered clinically depressed if he/she responds affirmatively to five of nine symptoms 
in which one of the symptoms is depressed mood and/or anhedonia (not wanting to do anything).
The Center for Epidemiological  
Studies depression (CES-d) Scale119
The CES-d was used to measure depressive mood during the past week. The CES-d consists of 20 items 
which are rated on a four-point scale according to how frequently they were experienced in the previous 
week: 1= rarely or none of the time (less than one day), 2= some or a little of the time (1–2 days),  
3= occasionally or a moderate amount of time (3–4 days), or 4= most or all of the time (5–7 days).
Spielberger State–Trait Anxiety  
Inventory (STAI)120
The STAI assesses feelings of tension, nervousness, and worry. The first 20 items measure state anxiety 
(how one feels at the moment) and the last 20 items measure trait anxiety (how one generally feels). 
Participants rate the frequency with which they feel or think in ways that indicate presence or absence 
of anxiety, eg, “I feel nervous and restless”, or “I feel pleasant” on a four-point scale (almost never, 
sometimes, often, almost always).
Perceived Stress Scale121 This four-item version of the scale measures perceived stress with items such as “How often have you felt 
difficulties were piling up so high that you could not overcome them?” Participants rate the frequency of 
the feeling on a five-point scale (0= never, through 4= very often).
Physical health
Physical symptoms122 Physical symptoms are assessed using a modification of the scale developed by the AIDS Clinical Trials 
Group. Participants are asked whether they have experienced each of a series of 38 possible symptoms in 
the preceding 30 days and how much the problem bothered them.
Cd4 and viral load Trained phlebotomists obtain approximately 15 ml of blood for Cd4 cell count and plasma HIV rNA 
viral load using the bdNA assay (Bayer, Emeryville, CA, uSA). Assays are run by Quest diagnostics, 
Madison, NJ, uSA.
Health behaviors
Sexual risk behaviors123 The sexual behavior questionnaire asks the number of male and female sexual partners in the past 3 
months, and whether the participant engaged in receptive anal sex with or without a condom, vaginal sex 
with or without a condom, receptive oral sex with or without a condom, and oral sex with or without a 
barrier. In addition, for each of the behaviors, the participant is asked how many of the partners he/she 
knew were HIV+.
Alcohol/drug use Alcohol use is assessed by asking how much beer, wine, and liquor the participant consumed in a typical 
week during the past month. drug use is assessed by asking which drugs were used in the past month 
to get high and how often in the past month they were used. response options include cocaine, crack, 
amphetamines, downers, marijuana, ecstasy, poppers, and other. Injection drugs are assessed separately 
and options include heroin, cocaine, crack, speed, and other. Participants are also asked whether they 
shared needles or cookers during the last 3 months, how many people they shared with in the past 
3 months, and how many times needles that were not cleaned were shared in the past 3 months. Finally, 
participants are asked how many HIV+ people they shared needles or cookers with in the last 3 months.
Medication adherence124,125 Participant adherence to antiretroviral therapy over the past 30 days is assessed using a visual analog scale. 
For each HIV medication prescribed, the participant is asked to indicate how much of each drug they 
have taken in the past 30 days by placing a line on a 10 cm scale marked from 0% to 100%. From this data, 
adherence can be calculated as an average across all medications. In addition, we ask how many doses 
were missed in the last 7 days.
(Continued)
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Table 1 (Continued)
Measure Description
Health attitudes and behaviors  
checklist126
This 27-item scale measures two underlying health behavior dimensions: preventative behaviors (eg, exercise) 
and risk-taking behaviors (eg, drinking). Responses are made on a five-point scale based on participants’ 
engagement in that health behavior in the past week. At Times 2, 3, and 4, we also assessed the extent to 
which participants were engaging in each of the eight skills taught in the intervention. For example, items such 
as “In the past week, how often did you set a goal and work toward it?” (goal setting) or “How often did you 
do something nice for someone else?” (acts of kindness) will be embedded with items from the checklist such 
as “How often did you exercise?” and “How often did you wear a seatbelt?”
Coping
Ways of Coping Scale127–131 Participants are asked to complete the coping items with reference to testing positive for HIV (at Time 1)  
or the most stressful situation associated with having HIV that occurred during the previous week  
(at Times 2, 3, and 4). The coping scale consists of a range of cognitive and behavioral strategies to cope 
with the stressful encounter, eg, “Talked to someone who could do something about the problem,” or 
“Went on as if nothing had happened” on a four-point scale (0= does not apply and/or not used; through 
3= used a great deal). The participant also responds on other scales hypothesized to be correlated with 
positive affect. The 23 assessed forms of coping responses include: confrontive coping, escape–avoidance, 
planful problem-solving, positive reappraisal, benefit, growth, mastery of stress, other success, purpose, 
positive relations with others, religion and respite, benevolent and negative religious coping, emotional 
processing and expression, goal replacement, and maintaining optimism.
Coping resources
Multidimensional Social  
Support Inventory132
This scale assesses practical, emotional, affirmational, HIV, negative, and general support. For each 
dimension of support, the respondent is asked whether there is someone to provide that type of support 
(yes/no); if yes, who that person is, and their relationship to the respondent. In addition to perceived 
availability of each type of support, respondents are asked how often they needed each type of support in 
the past month, and how often they actually received it. We will compute separate practical, emotional, 
affiliative, HIV, negative, and general support scales.
Moderators (assessed at Time 1 only)
NEO Five-Factor Inventory  
(NEO–FFI)133
The NEO–FFI is a 60-item scale that measures 12 aspects of each of five factors of personality 
(Neuroticism, Extraversion, Openness, Agreeableness, and Conscientiousness). Neuroticism has been 
shown to be associated with negative affect, and extraversion with positive affect, by rusting and larsen143 
The NEO–FFI has shown excellent reliability and validity in a wide variety of samples and has reasonable 
associations with coping (Costa et al144).
life Orientation Test–revised  
(lOT–r)134
Optimism, or generalized positive expectancies, will be assessed with the ten-item revised version of the life 
Orientation Test–revised. The lOT–r asks participants to rate their level of agreement with items such as 
“in uncertain times, I usually expect the best” on a six-point scale (0= strongly disagree, though 5= strongly 
agree). The lOT–r has good reliability, as well as excellent predictive and discriminant validity.
rosenberg Self-Esteem  
Scale (rSE)135
Self-esteem was assessed with the rSE, a ten-item measure that asks participants to rate their level of 
agreement to items such as “On the whole, I am satisfied with myself” on a five-point scale (1= strongly 
disagree, through 5= strongly agree). The rSE is the most widely used measure of self-esteem and has 
been shown to be reliable and valid in a wide variety of samples, including crack users (Falck et al145) and 
Spanish-speaking samples (Baños and Guillén146).
World Assumptions  
Scale (WAS)136
The 32-item WAS assesses people’s worldviews by asking them to rate their level of agreement with 
items such as “Most people can be trusted” and “Anyone can experience a very bad event” on a seven-
point scale (1= strongly agree, through 6= strongly disagree). The WAS assesses three main categories of 
assumptions: benevolence of the world, eg, “There is more good than evil in the world”, meaningfulness 
of the world, eg, “Through our actions, we can prevent bad things from happening to us”, and self-worth, 
eg, “I am very satisfied with the kind of person I am.” The subscales demonstrate good reliability across 
samples (between α =0.81 and 0.87).
Subjective socioeconomic  
status137
To assess subjective socioeconomic status, participants are presented with a drawing of a ladder with ten 
rungs that is described as follows “Think of this ladder as representing where people stand in our society. 
At the top of the ladder are the people who are the best off, those who have the most money, most 
education, and best jobs. At the bottom are the people who are the worst off, those who have the least 
money, least education, and worst jobs or no job.” They are then asked to place an X on the rung that 
best represents where they think they stand on the ladder.
Hassles and uplifts Scale138 Hassles/uplifts are assessed with a shortened (57-item) version of the Hassles and uplifts scale. Hassles 
are defined as “irritants – things that annoy or bother you” and uplifts are “events that make you feel 
good.” For each event on the Hassles/uplifts scale, the participant indicates whether it has been a hassle 
or an uplift since the last interview. The scale is scored by calculating separate hassle and uplift scores.
(Continued)
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Table 1 (Continued)
Measure Description
life Experiences Survey139 Major life events are assessed with a modified version of the Life Experiences Survey. We assess whether 
any of the 49 items on the scale occurred since the last assessment. For those that did occur, participants 
are asked to rate whether the event had a positive or negative impact.
Intervention-based mediators
Gratitude Questionnaire–6  
(GQ–6)140
Gratitude is measured with the GQ–6, a six-item scale that asks participants to rate their level of 
agreement with statements such as “I have so much in life to be thankful for” on a eight-point scale 
where 1= strongly disagree and 7= strongly agree. We modified the wording of specific items to capture 
experiences of gratitude in the past month.
Five-Factor Mindfulness Scale141 We assessed mindfulness using a revised version of the Five-Factor Mindfulness Scale used in our pilot 
work. The scale was shortened to contain 19 likert-type items, and slight changes were made to the 
wording of several items to ensure that they were appropriate for use with participants who had no 
prior meditation experience. respondents are asked to indicate how frequently they experience several 
facets of mindfulness, including present-centered awareness and attention (eg, “You find it difficult to stay 
focused on what’s happening in the present.” – reverse scored); non-judgment (eg, “You criticize yourself 
for having irrational or inappropriate emotions.” – reverse scored); and non-reactivity (eg, “When you 
have distressing thoughts or feelings, you just notice them and let them go”). response options range 
from 1= never to 5= always.
Coping Self-Efficacy Scale142 Personal strengths in the context of stress were assessed using the 13-item coping self-efficacy scale 
which measures self-efficacy in three main areas: using problem-focused coping (eg, “Break an upsetting 
problem up into smaller parts”), stopping unpleasant emotions and thoughts (eg, “Make unpleasant 
thoughts go away”), and getting support from family and friends (“Get friends to help you with the things 
you need”). Participants were asked to rate the degree to which they could perform the listed behaviors 
on an eleven-point scale: 0= cannot do at all, 5= moderately certain can do, and 10= certain can do. We 
added items to assess self-efficacy in increasing positive affect.
Abbreviations: AIDS, acquired immune deficiency syndrome; HIV, human immunodeficiency virus; HIV+, human immunodeficiency virus positive; RNA, ribonucleic acid; 
bdNA, branched deoxyribonucleic acid.
Session 3
In Session 3, we focus on the coping skill of positive 
reappraisal. The participant is introduced to the concept of 
appraisal, a person’s interpretation or judgment about the 
personal significance of an event. The facilitator explains 
that because our appraisals determine our emotional reaction 
to an event, if we can change our appraisals, we can change 
how we feel. Positive reappraisal is a way of dealing with 
stress in which the individual makes a positive change in how 
an event is interpreted or appraised. Noting that the event 
may not be as bad as originally thought, was not as bad as 
it could have been, or noting something positive that may 
come out of the event are all forms of positive reappraisal 
that are likely to be related to increased positive affect in the 
face of stress. The facilitator and participant then practice 
reappraising recent small events in the participant’s life. We 
explicitly do not focus on trying to reappraise the experi-
ence of testing positive for HIV. Instead we start with small, 
relatively minor events (eg, being late to work; encountering 
a rude person on the street; traffic) to develop the skill of 
positive reappraisal. Although it is not a proximal goal of the 
present intervention given its brief duration, with continued 
practice an individual can learn to positively reappraise 
virtually any event.109 Home practice consists of reporting a 
relatively minor stressor each day, then listing ways in which 
the event can be positively reappraised. The daily formal 
mindfulness practice (10 minutes of mindful breathing), 
the daily gratitude journal, and the brief emotion reports 
continue.
Session 4
In Session 4, we focus on the participant’s personal strengths 
and the process of setting (and attaining) achievable goals. 
The facilitator asks the participant to list his or her personal 
strengths or positive qualities. After the participant lists 
them, the facilitator then lists strengths that he has seen in the 
participant over the 4 weeks of the intervention. In our pilot 
work, this was a powerful positive experience for participants. 
It was particularly effective given that participants were in 
the midst of the stressful early months after HIV diagnosis. 
The next portion of the session concerns defining and setting 
attainable goals. We define attainable goals as having four 
characteristics: 1) they are realistic and can be reasonably 
completed in the allotted time; 2) they are clear; 3) they are 
challenging but not impossible or too global; and 4) they 
have a clear end point so it is obvious when the goal has been 
successfully completed. The facilitator then works with the 
participant to set some attainable goals for the coming week. 
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The home practice for Session 4 consists of listing a strength 
each day and how it was “expressed” behaviorally that day, 
working toward one of the goals each day, and noting progress 
each day. The 10-minute mindful breathing, the gratitude 
journal, and the daily affect reports continue this week.
Session 5
The focus in Session 5 is on altruistic behaviors or small 
acts of kindness. The previous 4 sessions encourage partici-
pants to focus on themselves. The purpose of Session 5 is to 
intentionally focus on other people. The facilitator empha-
sizes that even though the participant may be going through a 
very difficult time in his or her life, he/she can still help other 
people through small acts of kindness (including expressing 
gratitude to people who performed acts of kindness or helped 
care for them). In addition to the mindful breathing, daily 
gratitude journal, and daily affect reports, the home practice 
for Session 5 consists of doing one small act of kindness each 
day and noting it.
Session 6
Session 6 is conducted by phone and focuses on reviewing 
the previous week’s home practice, evaluation of each of the 
eight skills, evaluation of the intervention overall, and plan-
ning for continued practice of the skills.
Content of the control sessions
Participants in the control condition also have five one-on-
one sessions with a facilitator. The sessions are comparable 
in length to the intervention sessions (approximately one 
hour) but consist of an interview and do not have didactic 
portions or skills practice. These sessions were designed to 
remove the positive affect component of the intervention, 
while maintaining any nonspecific effects arising from 
one-on-one contact with a sympathetic facilitator and an 
opportunity to share one’s personal stories and concerns. 
The interviews include 1) life history (qualitative); 2) health 
history (qualitative), including use of complementary and 
alternative medicine and physical activity; 3) personality 
and diet questionnaires; 4) social support and social network; 
5) meaning and purpose; 6) (via telephone) the ranking of 
sessions as to whether participants would recommend the 
sessions to a friend; and 7) (via telephone) the participant’s 
rating of enjoyment of sessions.
Home practice for the control group consists of brief 
daily affect reports over the 5 weeks of the control sessions. 
At the start of sessions two through five, the facilitator 
reviews the previous week’s affect diary with the participant. 
After the Time 4 assessment (15 months post-diagnosis), 
 participants in the control condition are given the opportunity 
to access an online, self-paced version of the intervention.
Payment of participants
Participants are paid $20 for each intervention/control ses-
sion, $25 for the first two assessments, and $50 for each of 
the assessments at Time 3 and Time 4, for a total of $250 
for completing the entire study. In addition, we reimburse 
for transportation (eg, cab fare, bus fare, or parking) and 
provide a snack for each assessment and intervention/control 
session.
Training and intervention fidelity
There were two groups of staff, each of whom required 
different training: assessment interviewers (assessors) and 
session facilitators. All staff members received a minimum 
of 30 hours of training which took place over several weeks 
and included: 1) privacy and confidentiality training in Health 
Insurance Portability and Accountability Act (HIPAA) secu-
rity practices and human subjects protection; 2) technology 
training, including use of laptops, computer-assisted personal 
interview programs, digital audio software, and data tracking 
procedures on the study website; 3) training in interviewing 
techniques, which addressed building rapport, working with 
diverse populations, cultural sensitivity, population-specific 
issues and referrals, and basic quantitative and qualitative 
interview skills; 4) suicidality assessment protocol; 5) 
interview/session roleplays; and 6) site visits to locations 
where assessments and control/intervention sessions took 
place. Ongoing training provided updates on HIV treatment 
and weekly group supervision, and as-needed individual 
supervision to address individual cases and procedural 
issues for assessors and facilitators. Assessors received 
additional training in obtaining informed consent and the 
video recording protocol. Facilitators attended a separate 
training that included detailed overviews of the intervention 
approach and procedures. Specific techniques for adhering 
to a manualized intervention while allowing for flexibility to 
address individual participant needs were taught, role-played, 
and supplemented by instructional readings. Assessors and 
facilitators were bilingual and bicultural. The majority of staff 
conducting Spanish-language interventions and assessments 
were native Spanish speakers.
Following the training, staff conducted mock sessions. 
The audio recordings of these sessions were reviewed by the 
principal investigator and project director, who then met one-
on-one with interviewers/facilitators to provide feedback on 
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interviewing and intervention techniques. Mock interviews 
were repeated until assessors/facilitators were proficient 
with using software, familiar with delivery of quantitative 
questionnaires, skilled at conducting the qualitative portion 
of the interview and, for the intervention facilitators, were 
comfortable and familiar with each of the five intervention 
sessions.
Intervention fidelity training  
and monitoring
Monitoring of fidelity of intervention and control sessions 
during the course of the study included: 1) development of 
detailed curriculum manuals for each of the sessions; 2) inten-
sive training; 3) incorporation of mock training sessions that 
enabled us to ensure all facilitators met performance criteria 
for intervention/control session delivery; and 4) audio record-
ing of sessions. Audio recordings of facilitator sessions were 
reviewed by the project director to assess adherence to the 
protocol, delivery, interpersonal skills, facilitator/participant 
rapport, and session flow.
Measures
Detailed descriptions of the measures are provided in 
Table 1.
Planned analyses
The primary outcome measure is positive affect. Our first aim 
is to determine the efficacy of the intervention for increasing 
positive affect at Times 2, 3, and 4. The second aim tests posi-
tive affect as a mediator of intervention effects on psychologi-
cal well-being (eg, depression), health behaviors (eg, HIV 
transmission risk, engagement in care, medication adherence) 
and physical health (eg, CD4, viral load,  symptoms). The 
third aim tests moderation of intervention effects by baseline 
characteristics such as gender, race/ ethnicity, and personality 
(see Figure 1).
We will first examine baseline characteristics of the 
sample, stratified by experimental group, to ensure that 
key variables (positive affect, mental and physical health, 
and demographics) are indeed evenly distributed in the 
randomization. Before testing hypotheses, we will also 
examine the proportion of missing data at each time point 
in order to address any concern regarding possible bias due 
to differential attrition. Completers and dropouts will be 
compared on baseline variables using independent t and 
Fisher’s exact tests. Variables showing substantial group 
differences at baseline will be candidates for inclusion as 
covariates in tests of hypotheses.
Given that this study is a treatment evaluation, we will 
conduct intention-to-treat analyses. We will supplement 
these analyses with dose-response analyses, using ordinary 
or logistic regression, depending on whether outcomes are 
continuous or dichotomous, to test whether various measures 
of participation (eg, number of sessions attended, days of 
homework completed) affect outcomes.
Aim 1. Determine the efficacy of the Intervention for 
those Recently Informed of their Seropositive Status (IRISS) 
to increase frequency and intensity of our primary outcome, 
positive affect, during the intervention and at 5, 10, and 15 
months after diagnosis. Tests of intervention effects will be 
conducted with multiple-group growth models, with coef-
ficients chosen to reflect the hypothesized pattern of change. 
We expect frequency and intensity of positive affect, as 
measured, respectively, by the modified Differential Emotions 
Scale (mDES) and Positive and Negative Affect Schedule 
(PANAS) (see Table 1), to increase for the intervention group 
over the course of the intervention, and to be maintained 
thereafter. The most specific manifest-variable test of the 
hypothesis as a whole is the difference between groups on 
the contrast between baseline and the following three time 
points. On a more piecemeal basis, differences in means 
or in change scores can be tested with independent t-tests 
comparing the intervention to the control group.
Aim 2. Test the effects of IRISS on psychological and 
physical health and health behaviors, and determine whether 
increases in positive affect are responsible for improvements 
in these outcomes. The tests of effects here are the same as 
those in Aim 1, with different outcome variables. Some, like 
clinical depression, are binary, but these can be handled by 
Mplus (Muthén and Muthén, Los Angeles, CA, USA) through 
probit regression. Others, like viral load, are known to have 
strong positive skew and will be (log) transformed before 
analysis. Determining whether increases in positive affect 
are responsible for these changes requires mediation analysis. 
Since we expect both the outcomes and these potential 
“mediators” to be products of the intervention, with perhaps 
no clear separation in time, the first step in these analyses will 
be to examine whether changes in positive affect precede or 
coincide with changes in the outcomes. MacKinnon et al110 
conducted a Monte Carlo study of 14 procedures for testing 
mediation effects, found the classic method of Baron and 
Kenny111 unacceptably weak, and recommended testing the 
product of the coefficients in the mediation path by refer-
ence to the distribution of the product of two normal variates 
(which is not itself normal). As recommended by Shrout and 
Bolger112 we will use Mplus to bootstrap the product term. 
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Given the dependency of indirect effects on the time interval, 
for multiwave models we will compute overall, rather than 
time-specific, indirect effects.113
Aim 3. Evaluate the extent to which personality, sex, or 
race/ethnicity moderate the effects of IRISS on these out-
comes. Since we will be exploring moderation and mediation 
separately, moderation can be tested simply by the addition of 
interaction terms, with components appropriately centered.
Discussion
The first few months after HIV diagnosis provide a window 
of opportunity for intervention in which participants are 
establishing new patterns of sexual risk and health  behaviors. 
Although the period immediately following diagnosis is 
associated with significantly elevated levels of depression 
and anxiety, there are few interventions designed expressly 
for people newly diagnosed with HIV.
Based on increasing evidence from our research team 
and others that positive affect has adaptive functions in 
the context of health-related stress, we developed and are 
testing a theory-based positive affect skills intervention 
for people newly diagnosed with HIV. By emphasizing 
the importance of positive affect in the stress process we 
may appear to minimize the pain and serious individual 
and societal consequences associated with major stressful 
events. We are not advocating a simplistic “don’t worry, be 
happy” approach, nor do we believe that simply increasing 
positive affect will prove to be a cure-all for the very real 
and complex issues facing people newly diagnosed with 
HIV. Such a stance could easily degenerate into blam-
ing the victim for not thinking the positive thoughts that 
may prevent depression or other negative consequence of 
enduring stress.
However, an intervention to increase positive affect in the 
months after testing positive for HIV may set the stage for 
a cascade of adaptive consequences. In addition, the focus 
on positive affect will likely make the proposed interven-
tion more attractive to providers and participants alike, and 
serve as an antidote to the increasingly pervasive “prevention 
fatigue”.114–116
Further, in pilot testing this intervention we learned that 
participants were not the only ones whose positive affect 
increased; facilitators, staff, and investigators also experi-
enced increases in positive affect. Ultimately, given the high 
levels of stress, distress, and depression documented in this 
population of people newly diagnosed with HIV, we consider 
increasing positive affect to be an inherently worthwhile 
intervention goal.
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